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Abstract
Background: Diarrhea is an important cause of morbidity and mortality in all regions of the world and among all ages, yet
little is known about the fraction of diarrhea episodes and deaths due to each pathogen.
Methodology/Principal Findings: We conducted a systematic literature review to identify all papers reporting the
proportion of diarrhea episodes with positive laboratory tests for at least one pathogen in inpatient, outpatient and
community settings that met our inclusion and exclusion criteria. We identified a total of 25,701 papers with possible
etiology data and after final screening included 22 papers that met all inclusion and exclusion criteria. Enterotoxigenic
Escherichia coli and V. cholerae O1/O139 were the leading causes of hospitalizations. In outpatient settings, Salmonella spp.,
Shigella spp., and E. histolytica were the most frequently isolated pathogens.
Conclusions/Significance: This is the first systematic review which has considered the relative importance of multiple
diarrhea pathogens. The few studies identified suggest that there is a great need for additional prospective studies around
the world in these age groups to better understand the burden of disease and the variation by region.
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Introduction
Diarrhea is an important cause of morbidity and mortality in all
regions of the world and among all ages [1,2]. For children 5 years
of age and older, adolescents, and adults mild to moderate
diarrhea can lead to absenteeism from school or work and may
require treatment by a health care provider. More severe diarrhea
can lead to hospitalization; serious sequelae such as Guillain Barre’
syndrome and hemolytic uremic syndrome; and in some cases
death [3,4].
Though most diarrhea episodes are self limiting and dehydra-
tion can usually be controlled with oral rehydration therapy, it
would be ideal to be able to prevent diarrhea, especially the more
severe episodes which have a higher likelihood of progressing to
complications or death. Some prevention strategies such as
improved water and sanitation and basic hygiene practices are
generalizable and thus do not require knowledge of diarrhea
etiology, but others such as vaccines would benefit greatly from a
comprehensive understanding of the overall burden of pathogen-
specific diarrheal disease.
Recent advances have led to the development of an effective
rotavirus vaccine which is now recommended for young children
as part of the routine immunization schedule [5]. A vaccine for
cholera that could be useful in some settings in all ages has been
available for several years, and is now recommended by the WHO
for persons living in endemic areas [6]. The number of pathogens
that are responsible for diarrheal disease goes far beyond rotavirus
and Vibrio cholerae; however, the fraction of diarrhea episodes and
deaths due to each pathogen is unclear, and thus uncertainty may
inhibit prioritization of funding for research and disease control
programs.
There have been numerous studies conducted in countries
around the world to determine the presence of one or more
pathogens in diarrheal stools. While isolated studies provide
important pieces of information, it is difficult to draw conclusions
with regard to the importance of various pathogens without
looking at a complete spectrum of agents simultaneously. We
conducted a systematic literature review of diarrhea etiology
studies to better understand the likely distribution of pathogen-
specific diarrhea episodes and deaths in older children, adolescents
and adults. To our knowledge this is the first systematic review
designed to compile the data from multiple pathogens which might
be applied to annual incidence and mortality rates in these age
groups.
Methods
We searched PubMed/Medline, CAB abstracts, System for
Information on Grey Literature in Europe (SIGLE), and all World
Health Organization (WHO) Regional Databases for studies
published from January 1, 1980 through December 31, 2008 using
all combinations of the following search and MeSH terms:
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‘‘cause of death’’, and ‘‘gastroenteritis’’. The objective of the
search was to identify all papers reporting the proportion of
diarrhea episodes with positive laboratory tests for at least one
pathogen in in-patient, out-patient and community settings that
met our inclusion and exclusion criteria. We included studies
published in all languages and conducted in children $5 years,
adolescents and adults with at least 12 mo of surveillance
(multiples of 12 mo61 mo for longer studies) to minimize bias
due to seasonality of diarrhea pathogens. We excluded studies
enrolling only patients with clinical signs of dysentery, i.e. blood in
the stool, studies conducted in special populations such as
travelers, patients hospitalized for other reasons, or only HIV-
positive persons and all individual or outbreak case reports.
Studies that did not screen for HIV status and/or did not enroll
based on HIV status were included. All exclusion criteria were
chosen to ensure study populations represented the general
population in the study community. In addition, we assessed all
laboratory methods for appropriateness and if either incorrect or
inadequately described, we excluded the study.
We conducted individual searches in all databases and combined
the results to eliminate duplicates using RefWorks Reference
Manager [7]. We first reviewed titles for appropriateness and then
all abstracts as the first steps of the screening process. For all
abstracts with likely applicable data we ascertained the full text
article and screened for inclusion and exclusion criteria. All papers
meeting our inclusion andexclusioncriteria were then abstracted by
2 trained data abstractors into a standardized database. We
abstracted information with regard to study population, study
setting, diarrhea definition, prevalence of each pathogen, and
diarrhea definition required for inclusion in the study. After
completing both abstractions we cross checked the data and
rectified any differences. We initially included an extensive group of
diarrhea pathogens for data abstraction (Table 1), but included only
pathogens with available data in the final analyses. For inclusion in
the final analyses presented here, we included only studies that
adequately described where study participants were recruited from,
i.e. inpatient, outpatient, or community settings.
Laboratory methods for each pathogen were reviewed by a
laboratory expert (D. S.). Because laboratory techniques for
pathogens such as diarrheagenic E. coli and E. histolytica, have
changed since the mid 1990s, we included all studies with standard
laboratory procedures for the time of the study [8,9].
Analytic Methods
We first calculated the un-weighted mean, median and inter-
quartile range for each pathogen for each type of patient
population separately. There was only 1 community study [10]
so for all analyses we combined this study with the studies
conducted in outpatient settings. We then categorized inpatient
and outpatient studies based on the number of pathogens reported
by the authors in the methods and results sections of each
published study: single pathogen studies, those reporting 2–4
pathogens, and those reporting at least 5 pathogens. For each of
these categories we calculated the weighted mean for each
pathogen. Among inpatient studies we removed the 1 study
conducted in a high income setting to enable separate calculations
for high vs. low and middle income countries separately. We
stratified studies by inpatient or outpatient status and by the
number of pathogens identified in each study to present the best
possible summary data to approximate the most likely pathogen
distributions for diarrhea mortality and all episodes, respectively.
Results
Weidentified25,701paperswithpossibleetiologydata(Figure1).
After screening 5,986 abstracts and 932 papers, we found 45 that
met our inclusion and exclusion criteria. Twenty-two papers met all
inclusion and exclusion criteria and described the study populations
withregardtoinpatient,outpatientorcommunitystudypopulations
[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,
31,32] (Table 2). Twenty three additional papers met initial
screening criteria but were subsequently excluded from the
analysis presented here because they lacked information with
regard to the patient population (i.e. inpatient vs. outpatient) or
did not differentiate the results by population type (Table 3)
[20,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,
53].
Author Summary
Diarrhea is an important cause of illness and death around
the world and among people of all ages, but unfortunately
we often do not know what specific bacterium or virus
causes the illness. We conducted a review of the scientific
literature with the goal of finding published studies that
identified bacteria and viruses among patients with
diarrhea in the community and in hospital settings. We
initially found nearly 26,000 papers on this topic but
narrowed the list to 22 studies that met all of our specific
criteria for inclusion in our review. Among patients
hospitalized for diarrhea, E coli and Vibrio cholerae were
found in more than 49% of people living in middle income
and poor countries. Among patients who sought care from
their doctor on an outpatient basis, Salmonella spp.,
Shigella spp., and E. histolytica were most often found. In
our review we focused on the differences in the
distribution of pathogens between patients in inpatient
vs. outpatient settings because these estimates may best
approximate what we would expect to see if the
distribution were applied to global estimates of diarrhea
deaths vs. uncomplicated illnesses.
Table 1. Pathogens included in initial abstraction.
Enterohaemorrhagic Escherichia coli (EHEC) Campylobacter spp. Yersinia spp.
Enteroinvasive Escherichia coli (EIEC) Aeromonas spp Endolimax nana
Enterotoxigenic Escherichia coli (ETEC) Shigella spp. C. difficile
Enteropathogenic Escherichia coli (EPEC) Salmonella spp. Cryptosporidium spp.
Enteroaggregative Escherichia coli (EAEC) Giardia spp. E. histolytica
Calicivirus/Norwalk or related agents/Norovirus C. perfringens P. shigelloides
doi:10.1371/journal.pntd.0000768.t001
Systematic Review of Diarrhoea Etiology
www.plosntds.org 2 August 2010 | Volume 4 | Issue 8 | e768In table 4 we present the unweighted mean and median
proportion of stools which tested positive for each pathogen in
both in- and out-patient settings. In this analysis V. cholerae O1/
O139 and ETEC were the leading causes of hospitalization. In
inpatient populations Aeromonas spp. Yersinia spp. Cryptosporidium
spp., V. parahaemolyticus, P. shigelloides, and C. difficile were each
found in ,2% of patients. In out-patient settings, Salmonella spp.,
Shigella spp., and E. hystolitica were isolated the most frequently. In
outpatient populations, EHEC, Campylobacter spp., Aeromonas spp.
and Yersinia spp. were found in ,2% of patients. Very few studies
tabulated data such that the co-occurance of more than one
pathogen in a diarrheal stool could be ascertained and few tested a
broad enough spectrum of pathogens to be able to quantify the
proportion of episodes from which no currently recognized
pathogen could be identified.
In Table 5 we present the analysis of inpatient studies stratified
by the number of pathogens sought among those studies
conducted in low and middle income countries. We separately
present the results for the single analysis which included more than
4 pathogens conducted in a high income setting [19]. There were
very few single pathogen studies thus it is difficult to identify a
trend as one progresses from single to comprehensive studies with
at least 5 pathogens. In the studies conducted in low and middle
income countries which identified at least 5 pathogens, 28.1% of
hospitalized patients had tested positive for ETEC and 20.7%
tested positive for V. cholera O1/O139. For high income/low
mortality countries, one study found that 14% of hospitalized
patients tested positive for Campylobacter spp. followed by 11.5% of
samples testing positive for Salmonella spp. [19].
For outpatient studies we only identified studies of single
pathogens and those which looked for more than 4 pathogens
(Table 6). The difference in proportion of stools testing positive for
a particular pathogen is most noticeable for Shigella spp. where
34.3% of episodes were positive for Shigella in studies that sought
only that pathogen, vs. only 9.4% positive among studies which
looked for 5 of more pathogens.
Discussion
This is the first systematic review which has considered the
relative importance of multiple diarrhea pathogens for all regions of
the world among children 5 years and older, adolescents, and adults
using studies published in the peer reviewed literature. We stratified
our results by inpatient vs. outpatient settings because it is likely that
the distribution of pathogens differs by diarrhea severity. We found
ETEC and V. cholerae O1/O139 to be the most frequently isolated
pathogens among patients hospitalized for diarrhea; together they
were observed in more than 49% of samples from patients in low
and middle income countries. Because these studies were conducted
in cholera endemic areas this is not surprising; the importance of
cholera will depend on whether the study was done in an endemic
or epidemic area thus these results are not possible to generalize to
Figure 1. Results of systematic literature review.
doi:10.1371/journal.pntd.0000768.g001
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death among young children, was not found to be as important
among older persons providing additional evidence suggesting
immunity with increasing age.
In outpatient settings, Salmonella spp., Shigella spp., and E.
histolytica were the most frequently isolated pathogens. Because
little is known about the care-seeking behavior for community-
acquired diarrhea among children 5 years of age and older and
adults, additional data are needed in this age group to determine
the distribution of pathogens in the community. Because blood in
the stool is common for illnesses due to Shigella spp., Campylo-
bacter spp., and E. histolytica and may occur with Salmonella spp. it
is possible that the isolation of these pathogens would be higher
than in a true community-based setting due to an increase in care-
seeking behavior for illnesses with the presence of blood in the
stool. We only identified one community-based study; thus,
separate estimates for outpatient and community studies were
not possible.
The overall scarcity of the data used to produce these estimates
is a major limitation. This is particularly concerning when
generalizing across regions and when making assumptions about
variations which are likely among low, middle, and high income
countries based on variation in geography and risk factors. Given
the few studies meeting our criteria for inclusion in the review, it is
not possible to account for the additional differences in study
populations by region or over time which might have also
influenced the spectrum of pathogens due to changes in pathogens
chosen for isolation, pathogens circulating in a community, and
baseline characteristics of the study population.
An additional limitation of this review is the time span of the
included studies and thus heterogeneity of laboratory methods for
some key pathogens. In the last 30 years, diagnostic methods have
evolved for many pathogens, such as diarrheagenic E. coli and E.
histolytica. New laboratory methods, including PCR, and antigen
detection assays have increased sensitivity and decreased risk of
misclassification substantially. Because some reports included in this
Table 2. Study characteristics of community based, inpatient, and outpatient studies included in the final analyses.
Author (ref) Country
Date of data
collection
Study duration
in mos.
Age range
in yrs.
Sample
size Pathogens included in study
Community
Spencer [10] El Salvador 1977 12 $6 43 ETEC
Outpatient
Hossain [14] Bangladesh 1975–1984 120 $5 2488 Shigella spp.
Sitbon [17] Gabon 1980–91 12 $6 79 Rotavirus
Nath [23] India 1994–95 24 $59 1 6 Cryptosporidium spp.
Gassama [12] Senegal 1997–99 24 $18 121 EPEC/EAEC, Salmonella spp., Shigella spp., Campylobacter spp.,
Aeromonas spp., Rotavirus, Giardia, Cryptosporidium spp., E.
histolytica
Lau [15] China 2001–02 12 $5 906 Norovirus
MoezArdalan [21] Iran 2001–02 12 $53 1 2 Shigella spp.
Al-Gallas [26] Tunisia 2001–04 36 .18 73 EHEC, EIEC, ETEC, EPEC/EAEC, Salmonella spp., Shigella spp.,
Campylobacter spp., Aeromonas spp., Adenovirus, Rotavirus,
Giardia
Inpatient
Oberle [24] Bangladesh 1975 12 $5 1459 Salmonella spp., Shigella spp., V. cholerae O1
Zaman [32] Bangladesh 1978–87 120 $5 17129 Shigella spp.
Black [28] Bangladesh 1977–79 24 $10 5171 ETEC, Salmonella spp., Shigella spp., Rotavirus, Giardia, E.
histolytica, V. cholerae O1, V. parahaemolytica
Echeverria [31] Thailand 1980–81 12 .15 526 ETEC, Salmonella spp., Shigella spp., Rotavirus, Giardia, E.
histolytica, V. cholerae O1, V. parahaemolytica
Watson [19] UK 1982 12 $12 515 Salmonella spp., Shigella spp., Campylobacter spp., Aeromonas
spp., P. shigelloides, C. difficile
Poocharoen [25] Thailand 1983–93 12 5–15 17 Campylobacter spp.
Baqui [27] Bangladesh 1983–84 12 $5 1569 ETEC, Shigella spp., Campylobacter spp., Giardia, E. histolytica,
V. cholerae O1
Wasfy [18] Egypt 1986–93 96 5–23 6278 Salmonella spp., Shigella spp., Campylobacter spp.
Brandonisio [29] Italy 1987–94 84 9–14 28 Cryptosporidium spp.
Lim [16] Singapore 1989–90 12 $6 5181 Campylobacter spp.
Germani [13] New Caledonia 1990–91 24 $15 420 ETEC, EPEC/EAEC, Salmonella spp., Shigella spp.,
Campylobacter spp., Rotavirus, Giardia, E histolytica, C. difficile
Das [54] India 1989–91 24 $54 5 Cryptosporidium spp.
Vilchis-Guizar [30] Mexico 1995 12 39–51 2379 V. cholerae O1
Lau [15] China 2001–2002 12 $5 240 Norovirus
Nagamani [22] India 2003–06 48 .59 0 6 Cryptosporidium spp.
doi:10.1371/journal.pntd.0000768.t002
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these may under- or over-represent the prevalence of selected
pathogens. However, because of the overall paucity of data we chose
to include these studies however caution should be taken when inter-
preting the results for these selected pathogens for which laboratory
methods have improved dramatically over the past 30 years.
In this review we stratified studies by those that sought a single
pathogen and those that considered multiple pathogens. Because
single pathogen studies often pick study sites based on a known
prevalence of a particular pathogen it can be expected that the
observed rates would be higher than in studies where multiple
pathogens are being isolated. This was especially true for Shigella
spp. where we found the weighted mean dropped from 35.3% in
the single pathogen studies to 9.4% in the multiple pathogen
studies. In addition, outpatient studies did not look specifically for
some pathogens such as V. cholerae O1/O139 thus limiting the
inference about non severe episodes.
We recognize that we did not capture the true burden of every
possible pathogen that might cause diarrhea because many
pathogens occur in outbreaks and these may not have been
included in these ongoing disease surveillance studies. For example,
we only found one study that included detection of norovirus [15]
meeting our study inclusion criteria of at least 12 mo of surveillance.
Norovirus is known to be seasonal and a frequent cause of
epidemics, so may be underestimated in our review. Similarly
because we did not include outbreak data, pathogens that are more
typically observed in outbreaks may have been missed if they were
not known to be endemic in the study area.
Because we identified very few studies that tested for 5
pathogens or more and most were from South Asia, we were
not able to assess regional differences in pathogen importance. For
pathogens that are not known to be prevalent globally such as V.
cholerae O1/O139 this is especially problematic. Ideally unique
pathogen distributions would be developed for each region and for
large countries, such as Brazil, China, and India. National level
community-based surveillance and inpatient reports would enable
countries to better understand the local burden of disease by
pathogen and better design prevention programs.
Table 3. Study characteristics of studies meeting inclusion criteria but excluded from final analysis because the study population
(i.e. community-based, inpatient, or outpatient) was not given or results were not stratified by group.
Author (ref) Country
Date of data
collection
Study duration
(months)
Age in yrs
(mean ± range)
Sample
size Pathogens included in study
Echevarria [55] Thailand 1982–83 12 $5 177 ETEC, Shigella spp., Aeromonas spp., V.
cholerae, V. parahaemolyticus
Chatterjee [41] India 1982–83 24 5–14 46 EIEC, EPEC, Salmonella spp., Shigella spp., Campylobacter
spp., Rotavirus, Giardia, E. histolytica, V. cholerae, V.
parahaemolyticus, P. shigelloides
Cabrita [39] Portugal 1984–89 72 $5 1012 Salmonella spp., Shigella spp., Campylobacter spp.
Rahman [48] Bangladesh 1985 12 $65 7 7 Cryptosporidium spp.
Bingnan [38] Bangladesh 1987–89 24 $5 2370 Rotavirus
Zvizdic [53] Bosnia 1988–1991 48 5–7 70 Rotavirus
Cassel-Beraud
[40]
Madagascar 1988–89 12 6–14 113 ETEC, Salmonella spp., Shigella spp., Campylobacter
spp., Rotavirus, Giardia, E. histolytica
Zaman [20] Saudi Arabia 1989–90 12 $59 0 1 Campylobacter spp.
Libanorne [47] Italy 1984–87 24 16–96 1681 Giardia
Katsumata [46] Indonesia 1992–93 12 $52 1 1 Cryptosporidium spp.
Samonis [49] Greece 1992–94 36 $15 1420 EPEC, Salmonella spp., Shigella spp., Campylobacter
spp., Aeromonas spp.
Simadibrata [50] Indonesia 1995–2000 72 (42614) 207 Shigella spp.,Giardia, E. histolytica
Akinyemi [34] Nigeria 1995–96 12 $6 642 EHEC, EIEC, ETEC, EPEC, Salmonella spp., Shigella spp.,
Aeromonas spp.
Faruque [42] Bangladesh 1996–2001 72 $5 5779 ETEC, EPEC, Salmonella spp., Shigella spp., Campylobacter
spp., Rotavirus, E histolytica, V. cholerae
Bern [37] Guatemala 1997–98 12 $55 1 4 Cryptosporidium spp.
Gambhir [44] India 1997–2000 36 $15 145 Giardia, Cryptosporidium spp., E. histolytica
Battikhi [36] Jordan 1997–2001 48 $5 560 EPEC, Salmonella spp., Shigella spp., Campylobacter
spp., Rotavirus
von Seidlein [52] Multi-site Asia
1 2002 12 .5 8253 Shigella spp.
Abreu-Acosta
[33]
Spain 2002–2004 24 $13 17 Cryptosporidium spp.
Hamedi [45] Iran 2003 12 5–7 31 Cryptosporidium spp.
Uchida [51] Nepal 2003–04 12 $5 645 Rotavirus
Amarilla [35] Paraguay 2004–05 24 18–95 801 Rotavirus
Feizabadi [43] Iran 2004–05 12 5–14 79 Campylobacter spp.
1China, Thailand, Indonesia, Vietnam, Pakistan, Bangladesh.
doi:10.1371/journal.pntd.0000768.t003
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yet we recognize that this is not the case for many diarrhea
episodes. Many patients have multiple pathogens and likewise for
some patients, no pathogen is found. Because we had very few
studies seeking multiple pathogens and even fewer reporting mixed
infections, we were not able to conduct a more complex analysis to
control for the role of multiple infections. We also recognize that
the identification of a pathogen in the stool does not necessary
Table 4. Isolation of pathogens by inpatient and outpatient/community settings.
Inpatient (15 total studies) Outpatient/Community (8 total studies)
Pathogen Mean (# of studies included) Median [IQR] Mean (# of studies included) Median [IQR]
Adenovirus – – 7 (1) 7 [NA]
Aeromonas spp. 0.2 (1) 0.2 [NA] 0.8 (2) 0.8 [0.4, 1.2]
Campylobacter spp. 4.1 (6) 1.4 [0.5, 5.9] 1.5 (2) 1.5 [1.5, 1.6]
C. difficile 1.5 (2) 1.5 [0.7, 2.2] – –
Cryptosporidia spp. 1.9 (3) 1.3 [0.9, 2.2] 6.4 (2) 6.9 [4.9, 7.0]
E. histolytica 3.1 (3) 2.3 [2.1, 3.3] 10.7 (1) 10.7 [NA]
EPEC/EAEC 4.0 (1) 4.0 [NA] 4.7 (2) 4.7 [3.7, 5.6]
ETEC 14.0 (4) 9.5 [3.4, 20.2] 5.9 (2) 5.7 [3.5, 8.1]
EHEC – – 0 (1) 0 [NA]
EIEC – – 4 (2) 4 [2.7, 5.3]
Giardia spp. 2.5 (3) 2.2 [2.2, 2.6] 2.5 (2) 2.5 [1.2, 3.7]
Norovirus 10 (1) 10 [NA] 8.5 (1) 8.5 [NA]
P. shigelloides 0.2 (1) 0.2 [NA] – –
Rotavirus 3.1 (3) 4.1 [2.0, 4.7] 2.1 (3) 2.3 [1.9, 2.4]
Salmonella spp. 8.4 (5) 3.3 [2.3, 11.4] 20.4 (2) 20.4 [13.5, 27.3]
Shigella spp. 6.5 (8) 4.3 [3.0, 10.2] 19.6 (4) 18.5 [10.3, 27.8]
V. cholerae (O1/O139) 15.3 (5) 14.0 [11.9, 30.2] – –
V. parahaemolyticus 1.6 (2) 1.6 [0.8, 2.4] – –
Yersinia spp. 0 (1) 0 [NA] 0 (1) 0 [NA]
doi:10.1371/journal.pntd.0000768.t004
Table 5. Isolation of single vs. multiple pathogens among inpatients.
Weighted mean % (# of studies) for low and middle income countries One study representing high income countries [19]
Pathogen
Single Pathogen
Studies
2–4 Pathogens
Studies
.4 Pathogen
Studies
Percent of patients positive
for each pathogen
EPEC/EAEC – – 4 (1)
ETEC – – 28.2 (4)
Salmonella spp. – 2.7 (2) 12.3 (2) 11.5
Shigella spp. 0.2 (1) 3.7 (2) 6.7 (4) 3.1
Campylobacter spp. 0.5 (2) 2.3 (2) 5.7 (2) 14
Cryptosporidia spp. 1.3 (3) – –
Aeromonas spp. – – 0.2
Yersinia spp. – – 0 (1)
Giardia spp. – – 2.2 (3)
Rotavirus – – 3.9 (3)
Norovirus 10 (1) – –
V. cholerae O1/O139 11.9 (1) 30.2 (1) 20.7 (3)
V. parahaemolyticus – – 0.3 (2)
E. histolytica – – 3.8 (3)
P. shigelloides –– 0 . 2
C. difficile – – 0.2 (1) 2.9
doi:10.1371/journal.pntd.0000768.t005
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asymptomatic carriers and thus the prevalence of some pathogens
might be found at the similar proportions in healthy individuals.
These pathogens have a lower pathogenicity than those that are
never or rarely identified in the stools of asymptomatic individuals.
Only one study in our final data set provided data for
asymptomatic controls, thus a full analysis to control for
asymptomatic carriage was not possible.
This study is the first to systematically review the literature on
the etiology of diarrhea in children $5 years of age, adolescents
and adults and provides an important overview of the distribution
of pathogens responsible for both infection and possible death.
The few studies identified suggest that great caution must be taken
when interpreting these limited data. Many limitations have been
identified suggesting the need for additional prospective studies
around the world in these age groups. Understanding the burden
of pathogen specific diarrheal disease and the variation by region
is important for planning effective control programs for the overall
reduction of diarrhea disease among persons of all ages.
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